Regenxbio (RGNX) Receivables - Other (2017 - 2025)
Regenxbio (RGNX) has 10 years of Receivables - Other data on record, last reported at $104000.0 in Q4 2025.
- For Q4 2025, Receivables - Other fell 56.49% year-over-year to $104000.0; the TTM value through Dec 2025 reached $104000.0, down 56.49%, while the annual FY2025 figure was $104000.0, 56.49% down from the prior year.
- Receivables - Other reached $104000.0 in Q4 2025 per RGNX's latest filing, up from $93000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $33.5 million in Q2 2022 and bottomed at $28000.0 in Q2 2025.
- Average Receivables - Other over 5 years is $7.1 million, with a median of $1.1 million recorded in 2021.
- Peak YoY movement for Receivables - Other: surged 5242.29% in 2021, then crashed 99.71% in 2025.
- A 5-year view of Receivables - Other shows it stood at $1.1 million in 2021, then skyrocketed by 2416.48% to $27.0 million in 2022, then plummeted by 81.5% to $5.0 million in 2023, then tumbled by 95.22% to $239000.0 in 2024, then crashed by 56.49% to $104000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $104000.0 in Q4 2025, $93000.0 in Q3 2025, and $28000.0 in Q2 2025.